The pharmacokinetics of single and multiple doses of intravenous paracetamol in children - Pharmacokinetics of I.V paracetamol in childre
- Conditions
- There is no medical condition to be investigated. This is a pharmacokinetic study to be performed in children routinely treated with intravenous paracetamol for post surgical pain in line with local treatment protocol.
- Registration Number
- EUCTR2009-012585-30-GB
- Lead Sponsor
- HS Grampian Research and Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Children under 16 years of age administered intravenous paracetamol for routine post-operative pain relief following elective surgery, according to local treatment protocol.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Patients will be excluded from the study for:
1: The anaethetist does not anticipate that the child will require post surgical intravenous paracetamol;
2: Routine evidence of liver dysfunction;
3: Routine evidence of renal impairment;
4: Known hypersensitivity to paracetamol or any of the components of the intravenous formulation of paracetamol:
5: Prior use of paracetamol within 24 hours of the study; and
6: Parental or child objection to study participation
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Secondary Objective: ;Primary end point(s): Blood paracetamol concentration with time;Main Objective: The objective of this research is to assess how the age, weight, height and body surface area of a child affects the metabolism an excretion of intravenous paracetamol given to relieve post-operative pain.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.